FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362592511> ?p ?o ?g. }

• W4362592511 endingPage "1932" @default.
• W4362592511 startingPage "1932" @default.
• W4362592511 abstract "Abstract Background: Colorectal cancer (CRC) is the 4th most common cancer type in the US. Following CRC treatment, about 37% of CRC survivors experience symptoms associated with anxiety and depression. Additionally, psychosocial distress is especially prevalent among CRC survivors with a stoma, and those reporting CRC-induced sexual dysfunction. Pharmacotherapy is one of the mainstay treatment options for psychological distress among patients with CRC. Research has shown that racial disparities are present with the use of supportive care medications in other cancer types. However, this has not been explored with the use of psychotropic medication for patients with CRC. The purpose of this research is to evaluate the presence of racial disparities in psychotropic medication use among patients with CRC. Methods: Utilizing the National Cancer Institute Surveillance Epidemiology and End Results (NCI SEER)- Medicare linked database, our analysis included all patients with a CRC diagnosis and an active outpatient prescription claims for psychotropic medications from 2009-2018. Prescription claims were specific to patients diagnosed with CRC and stratified by self-identified race and ethnicity. Patients who were on psychotropic medications before CRC diagnosis, or unspecified race or ethnicity were excluded from the analysis. Psychotropic medications consisted of anxiolytics, antidepressants, and antipsychotic medications. Results: 136,014 participants were included in the analysis. The racial and ethnic breakdown comprised of 81.56% White, 11.22% African American (AA), 2.66% Hispanic, 4.27% Asian/Pacific Islander (API), and 0.25% Native American (NA). Results are presented as unadjusted odds ratios (OR) and 95% confidence intervals (CI). Compared to White patients, AA (OR 0.53; 95% CI 0.50-0.56), API (OR 0.50; 95% CI 0.46-0.54), Hispanic (OR 0.64; 95% CI 0.58-0.71), and NA (OR 0.59; 95% CI 0.43-0.81) patients had lower utilization of anxiolytic medications. Regarding antidepressant use, AA (OR 0.55; 95% CI 0.53-0.57), API (OR 0.46; 95% CI 0.43-0.49), Hispanic (OR 0.73; 95% CI 0.68-0.79), and NA (OR 0.78; 95% CI 0.63-0.96) had lower utilization compared to White patients. Differences in antipsychotic medication use was observed with Asian/Pacific Islanders (OR 0.71; 95% CI 0.64-0.78) and Native Americans (OR 0.49; 95% CI 0.31-0.76) compared to White patients. No other racial differences in antipsychotic medications were identified. Conclusion: The study showed that racial and ethnic disparities are present with the use of psychotropic medications among patients with CRC. Racial and ethnic minority patients had lower use for most of the drug classes evaluated. Further research is warranted to assess the potential barriers and facilitators of psychotropic medication use among patients belonging to historically minoritized racial and ethnic groups. Citation Format: MegCholack Awunti, Yi Guo, Sherise Rogers, Lisa Scarton, Diana Wilkie, John Allen. Evaluation of racial and ethnic psychotropic medication use among patients with colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1932." @default.
• W4362592511 created "2023-04-06" @default.
• W4362592511 creator A5005692020 @default.
• W4362592511 creator A5044840043 @default.
• W4362592511 creator A5051632076 @default.
• W4362592511 creator A5052505769 @default.
• W4362592511 creator A5068830002 @default.
• W4362592511 creator A5075647270 @default.
• W4362592511 date "2023-04-04" @default.
• W4362592511 modified "2023-09-28" @default.
• W4362592511 title "Abstract 1932: Evaluation of racial and ethnic psychotropic medication use among patients with colorectal cancer" @default.
• W4362592511 doi "https://doi.org/10.1158/1538-7445.am2023-1932" @default.
• W4362592511 hasPublicationYear "2023" @default.
• W4362592511 type Work @default.
• W4362592511 citedByCount "0" @default.
• W4362592511 crossrefType "journal-article" @default.
• W4362592511 hasAuthorship W4362592511A5005692020 @default.
• W4362592511 hasAuthorship W4362592511A5044840043 @default.
• W4362592511 hasAuthorship W4362592511A5051632076 @default.
• W4362592511 hasAuthorship W4362592511A5052505769 @default.
• W4362592511 hasAuthorship W4362592511A5068830002 @default.
• W4362592511 hasAuthorship W4362592511A5075647270 @default.
• W4362592511 hasConcept C118552586 @default.
• W4362592511 hasConcept C121608353 @default.
• W4362592511 hasConcept C126322002 @default.
• W4362592511 hasConcept C150966472 @default.
• W4362592511 hasConcept C156957248 @default.
• W4362592511 hasConcept C2426938 @default.
• W4362592511 hasConcept C2908647359 @default.
• W4362592511 hasConcept C3020641676 @default.
• W4362592511 hasConcept C526805850 @default.
• W4362592511 hasConcept C558461103 @default.
• W4362592511 hasConcept C71924100 @default.
• W4362592511 hasConcept C98274493 @default.
• W4362592511 hasConcept C99454951 @default.
• W4362592511 hasConceptScore W4362592511C118552586 @default.
• W4362592511 hasConceptScore W4362592511C121608353 @default.
• W4362592511 hasConceptScore W4362592511C126322002 @default.
• W4362592511 hasConceptScore W4362592511C150966472 @default.
• W4362592511 hasConceptScore W4362592511C156957248 @default.
• W4362592511 hasConceptScore W4362592511C2426938 @default.
• W4362592511 hasConceptScore W4362592511C2908647359 @default.
• W4362592511 hasConceptScore W4362592511C3020641676 @default.
• W4362592511 hasConceptScore W4362592511C526805850 @default.
• W4362592511 hasConceptScore W4362592511C558461103 @default.
• W4362592511 hasConceptScore W4362592511C71924100 @default.
• W4362592511 hasConceptScore W4362592511C98274493 @default.
• W4362592511 hasConceptScore W4362592511C99454951 @default.
• W4362592511 hasIssue "7_Supplement" @default.
• W4362592511 hasLocation W43625925111 @default.
• W4362592511 hasOpenAccess W4362592511 @default.
• W4362592511 hasPrimaryLocation W43625925111 @default.
• W4362592511 hasRelatedWork W2057837861 @default.
• W4362592511 hasRelatedWork W2065895388 @default.
• W4362592511 hasRelatedWork W2163053290 @default.
• W4362592511 hasRelatedWork W2235119742 @default.
• W4362592511 hasRelatedWork W2392730113 @default.
• W4362592511 hasRelatedWork W2605450944 @default.
• W4362592511 hasRelatedWork W2995980286 @default.
• W4362592511 hasRelatedWork W3004259476 @default.
• W4362592511 hasRelatedWork W4297832689 @default.
• W4362592511 hasRelatedWork W4362716238 @default.
• W4362592511 hasVolume "83" @default.
• W4362592511 isParatext "false" @default.
• W4362592511 isRetracted "false" @default.
• W4362592511 workType "article" @default.